Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
US7138137B2 · kind B2 · utility
2Cited by
10References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 27, 2002 |
| Grant date | Nov 21, 2006 |
| Priority date | — |
| Expiry date | Mar 23, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are formulations of a stable paroxetine hydrochloride tablet comprising paroxetine hydrochloride, povidone or copovidone as a binder, and an HCl free/non-hygroscopic filler, prepared by the wet granulation method. Preferably, the paroxetine hydrochloride is paroxetine hydrochloride hemihydrate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.